European Psychiatry: Volume 17 - Issue S1

European Psychiatry

Only show content I have access to (961)

Over 3 years (961)

View selected items
Save to my bookmarks
Export citations
Download PDF (zip)
Save to Kindle
Save to Dropbox
Save to Google Drive
Save content to
To save this undefined to your undefined account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your undefined account. Find out more about saving content to .

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Please be advised that item(s) you selected are not available.
You are about to save
European Psychiatry
ISSN: 0924-9338

EISSN: 1778-3585

URL: /core/journals/european-psychiatry
Your Kindle email address

Please provide your Kindle email.

@free.kindle.com @kindle.com (service fees apply)

By using this service, you agree that you will only keep content for personal use, and will not openly distribute them via Dropbox, Google Drive or other file sharing services

European Psychiatry

Refine listing

Actions for selected content:

Volume 17 - Issue S1 - May 2002

P02. Antipsychotics

Posters, Sunday, 5 May 2002

Application of rispolept at heroin addiction in outpatient practice

Patient attitude after switch to ziprasidone from other antipsychotics

Aripiprazole and risperidone versus placebo in schizophrenia

Increased rates of antipsychotic-induced eps in mania: myth or reality

Controlled study of aripiprazole and haloperidol in schizophrenia

Ziprasidone vs amisulpride for negative symptoms of schizophrenia

Aripiprazole: a dopamine-serotonin system stabilizer

Smooth and safe transition from intramuscular to oral olanzapine

Risperidone and quetiapine for treatment-resistant schizophrenia

Neurocognitive effects: aripiprazole vs olanzapine in stable psychosis

Calming versus sedative effects of IM olanzapine in agitated patients

QTc intervals: IM olanzapine treatment in acutely agitated patients

Risperidone and olanzapine in inpatient treatment of bipolar disorder

Atypical antipsychotics in schizophrenia and mood disorder

Meta-analysis of the efficacy of aripiprazole in schizophrenia

Safety and tolerability meta-analysis of aripiprazole in schizophrenia

Risperidone monotherapy in secondary prophylaxis of affective and schizoaffective disorders

Atypical antipsychotics in Parkinson’s disease organic psychosis

New antipsychotics in acute psychosis with spontaneous dyskinesia

Amisulpride vs olanzapine in schizophrenia. Preliminary results on short-term analysis

European Psychiatry

Refine listing

Actions for selected content:

Save Search

Volume 17 - Issue S1 - May 2002

P02. Antipsychotics

Posters, Sunday, 5 May 2002